ITEM#: 3042-SBP3500374005MG
MFR#: SBP3500374-0.05MG
TLR5 Blocking Peptide for SAB3500374
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
TLR5 BLOCKING PEPTIDE 50 UG | TLR5 Blocking Peptide, BioVision Inc - 3555RBP-50, 50 μg, 50 µg blocking peptide for TLR5 (Toll-li | 3279-3555RBP50 | EA | |
TLR5 PEPTIDE | Human TLR5, Synthetic Peptide, Invitrogen, Quantity: 50ug, Accession Number: O60602, Common Name: Human TLR5, Concentration: 200ug/mL, Cross Reactivity: Human, Description: Synthetic Peptide, Format: Liquid, Formulation: PBS with 0.1% BSA a | 3136-PEP0316 | EA | |
TLR5 PEPTIDE | Human TLR5, Synthetic Peptide, Invitrogen, Quantity: 50ug, Accession Number: O60602, Common Name: Human TLR5, Concentration: 200ug/mL, Cross Reactivity: Human, Description: Synthetic Peptide, Format: Liquid, Formulation: PBS with 0.1% BSA a | 3136-PEP0315 | EA | |
Anti-TLR5 antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | Anti-TLR5 antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 3042-SAB3500374100UG | EA | |
ORAI1 Blocking Peptide for SAB3500412 | ORAI1 Blocking Peptide for SAB3500412 | 3042-SBP3500412005MG | EA | |
OCLN Blocking Peptide for SAB3500301 | OCLN Blocking Peptide for SAB3500301 | 3042-SBP3500301005MG | EA | |
Wnt10a Blocking Peptide for SAB3500393 | Wnt10a Blocking Peptide for SAB3500393 | 3042-SBP3500393005MG | EA | |
Betatrophin Blocking Peptide for SAB3501080 | Betatrophin Blocking Peptide for SAB3501080 | 3042-SBP3501080005MG | EA | |
CIP75 Blocking Peptide for SAB3500075 | CIP75 Blocking Peptide for SAB3500075 | 3042-SBP3500075005MG | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.